Rozenn Le Berre
Université de Bretagne Occidentale
1 paper in the Anchorcite directory, published in 2016, cited 5,008 times in total.
ORCID profileResearch topics
- Immunodeficiency and Autoimmune Disorders · 1 paper
- Cystic Fibrosis Research Advances · 1 paper
- Phosphodiesterase function and regulation · 1 paper
Frequent co-authors
- Laurent Meijer · 1 paper
- Deborah J. Nelson · 1 paper
- Vladimir Riazanski · 1 paper
- Aida G. Gabdoulkhakova · 1 paper
- Geneviève Héry-Arnaud · 1 paper
- Nadège Loaëc · 1 paper
- Nassima Oumata · 1 paper
- Hervé Galons · 1 paper
Papers
- Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic FibrosisJournal of Innate Immunity · 2016 · 5,008 citations
(R)-Roscovitine, a pharmacological inhibitor of kinases, is currently in phase II clinical trial as a drug candidate for the treatment of cancers, Cushing's disease and rheumatoid arthritis. We here review the data that support the investigation of (R)-roscovitine as a…
Metadata from OpenAlex (CC0).